Registered business in Herstal · BE. Official registry identity, filed financial evidence and a public indicative value curve on one indexed company profile.
Historical indicative ranges based on public filings. This is not an asking price or confirmation that the company is for sale.
Based on filed company accountsThe historical value curve is public. Create a free account for the future five-year growth outlook, the insights behind it, and concrete action points that can increase this company’s value.
Free account · private workspace
Each step adds evidence that narrows the range. Public filings are a starting point. Connected accounts, owner context and method review make the valuation more useful for real decisions.
Own this company? Claim and manage the profileYou have seen the historical curve. Create a free account to explore a private five-year value scenario and the assumptions behind it.
The valuation for Sartorius Xpress Biologics combines official public company figures with Upswitch sector calibration. The owner can sharpen it with their own figures and context into a full, defensible valuation curve.
Express interest and ask Upswitch to discreetly sound out the owner. We review every request before making contact.
This is an estimate, not an asking price. It is based on dated public sources and is not an owner forecast, offer, investment advice, or confirmation that the company is for sale.
Request verified control to add current figures, improve the profile and manage what happens next. We verify ownership before granting access.
Operating as a business in NACE sector 21100, Sartorius Xpress Biologics is registered in Herstal, Belgium. The company was founded in 2014, incorporated as a Naamloze vennootschap.
Sartorius Xpress Biologics is listed in Belgian Crossroads Bank for Enterprises (KBO) under registry number 0550686915 and VAT number BE0550686915. This profile consolidates Kbo Open Data, NBB/CBSO annual accounts into one indexable company dossier.
Within the Belgian NACE 21100 cluster, public-record data is filed annually via the national company registry.
Across the 2024-2025 window revenue has declined, moving from €3,605,368 to €2,406,103. EBITDA for 2025 comes in at -€4,716,424.
A public indicative value curve is available for Sartorius Xpress Biologics, based on filed company accounts. A free account unlocks the five-year outlook and concrete actions to increase value.
The most recent annual filing covers 2025 (period end 2025-12-31).
This page is refreshed whenever new regulator-filed data for Sartorius Xpress Biologics becomes available, consolidated into a single audit-grade view.
Public regulator-filed figures across 2 years.
Fiscal year | Revenue | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €2,406,103 | -€4,716,424 | €10,920,916 | -€9,487,789 | - |
| 202431 Dec 2024 | €3,605,368 | -€580,600 | €11,657,055 | -€2,828,170 | - |
Sartorius Xpress Biologics was founded in 2014 and is registered with Belgian Crossroads Bank for Enterprises (KBO), incorporated as a Naamloze vennootschap.
Sartorius Xpress Biologics is registered under NACE 21100: NACE 21100. That places the business within the Belgian cluster for this activity.
According to the company registry, Sartorius Xpress Biologics is based in Herstal, BE.
The most recently filed annual accounts cover fiscal year 2025 (period end 2025-12-31), publicly available via Belgian Crossroads Bank for Enterprises (KBO).
This page shows a rounded, automated indicative range generated by Upswitch from official registry facts, public company-size information, filed accounts where available, and governed sector benchmarks. The evidence basis is labelled beside the graph. It is not a certified or statutory valuation, sale price, offer, recommendation, or financial, investment, tax or legal advice. Figures for Sartorius Xpress Biologics may be incomplete or inaccurate and must not be relied upon for any transaction; a precise valuation needs owner- or advisor-supplied data.
Company identity and public facts are reused from the official or licensed source named on this page, with its filing or update date. Upswitch estimates remain distinct from source facts and do not imply endorsement by the registry. Natural-person enterprises are excluded from public valuation pages, and public registry personal data is not used for direct marketing.
Connected to this company and want something corrected? Request a correction or removal · Privacy policy · Terms & conditions · Data sources & evidence
Public profiles for peers in the same industry and country. Click through to compare filings and indicative valuations.
